Skip to content
healthcare.dev

MECLIZINE

NDC 16103-386, Meclizine HCl 12.5 mg, tablet, from Pharbest Pharmaceuticals, Inc..

Product NDC
16103-386
Status
Listed
Labeler
Pharbest Pharmaceuticals, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M009
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/16103-386 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MECLIZINE HYDROCHLORIDE12.5 mg/1

Pharmacologic classes

Antiemetic [EPC]; Emesis Suppression [PE]

Package NDCNDC-11Package
16103-386-0816103038608100 TABLET in 1 BOTTLE, PLASTIC (16103-386-08)
16103-386-11161030386111000 TABLET in 1 BOTTLE, PLASTIC (16103-386-11)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 16103-386 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/16103-386 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 16103-386. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.